Fast Biotechnologies

Life Science Accelerator Baden-Württemberg Batch 7

Fast Biotechnologies through its patented molecular detection technology intends to empower clinicians to quickly act and initiate early intervention measures by providing accurate diagnostic quantification of infectious agents within complex physiological fluids such as blood, urine, sputum, etc. Of particular interest, is the medical condition of sepsis.